Needham & Company on Impax Labs (IPXL): Not a Strategic Game-Change but Zomig Offsets SG&A Ramp and Provides Short-Term EPS Boost
Go back to Needham & Company on Impax Labs (IPXL): Not a Strategic Game-Change but Zomig Offsets SG&A Ramp and Provides Short-Term EPS Boost| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 4,114,601 | |||||
| IMPAX LABORATORIES, Inc. (NASDAQ: IPXL) | Delayed: 18.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $18.30 | 52 Week High | $45.00 | |||
| Open | $0.04 | 52 Week Low | $13.35 | |||
| Day High | $18.30 | P/E | 12.45 | |||
| Day Low | $18.30 | EPS | $1.47 | |||
| Volume | 10,600 | |||||

